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Evaluation of the Young Children with Neurodevelopmental Disability:
 A Prospective Study at Hamadan University of Medical Sciences Clinics 
Abstract
Objective
Developmental impairment is a common problem in children health 
that occurs in approximately 5–10% of the childhood population. The 
aim of this study was to determine the etiologic yield of subspecialists’ 
evaluation of young children with developmental disability.
Materials & Methods
All children aged between 2 months and 5 years referred over a 15-month 
period to Hamadan University of Medical Sciences subspecialty services 
for initial evaluation of a suspected developmental Disability, were 
enrolled in the present study. Diagnostic yield was determined after the 
completion of clinical assessments and laboratory tests requested by the 
evaluating physician.
Results
A total of 198 children (129 boys and 69 girls) were eligible for our 
study. 108 children had global developmental delay and 90 children 
had isolated developmental delay. Approximately ¼ of all patients did 
not have any specific etiology for developmental disability. Cerebral 
palsy (CP) was the most common clinical syndrome in all patients 
(41.4%). Hypoxic ischemic encephalopathy (13.8%), brain dysgenesis 
(13%), genetic disorder (13%), and  neurodegenerative  diseases  (11%) 
were determined in more than one half of all children with global 
developmental disability. in our study, “developmental speech delay” 
was the common cause of isolated speech delay.
Conclusion
Determination of an underlying etiology is an essential part of specialty 
evaluation of young children with developmental disability. The results 
of this study were similar closely to the results of other studies.
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Introduction
Developmental impairment is a common problem in children health (1) and occurs 
in approximately 5–10% of the childhood population (2). As such, it is a frequent 
reason for referral of a child for specialty evaluation by a pediatric neurologist (1). 
Based on the percentage of physicians citing neurologic disorders in their practice, 
developmental delay is one of the top common conditions after ADHD and epilepsy 
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Chromosomal microarray (CMA) is increasingly 
used for genetic testing of patients with unexplained 
developmental delay/intellectual impairment (11). The 
clinical implementation of array comparative genomic 
hybridization (CGH Array) has been a revolution in the 
diagnosis of patients with syndromic or nonsyndromic 
mental retardation and in patients with normal karyotype 
has detected chromosome abnormalities in up to 17% of 
cases (12). Inborn errors of metabolism (IEM) has been 
found to be the causes of developmental delay in a small 
percentage of these cases (1-5%) (2). 
This study aimed to determine common underlying 
etiologies in our patients and to help us for appropriate 
management of children with developmental disorders.  
Materials & Methods
Between January 2011 to March 2012 (a 15-month 
period), all children aged 2 months to 5 years referred 
to the Pediatric Neurology Clinics (Imam Khomeini and 
Besat Hospitals) of the Hamadan University of Medical 
Sciences, were identified prospectively.
Eligibility requirements were 2 month to 5 years old of 
age and referral for the initial evaluation of a suspected 
developmental disability. Children were excluded from 
subsequent data analysis if a developmental delay was 
not confirmed or they could not attend all the necessary 
diagnostic investigations. The survey included all 
children with neurodevelopmental disability (according 
to initially abnormal Denver II test) and finally confirmed 
by clinical judgment of a child neurologist (13). Besat 
and Emam Khomeini centers are the main referral 
centers for pediatric neurologic disorders in the west of 
Iran with near 200 and 600 attending patients monthly. 
This study was approved by the Research Committee of 
Hamadan University of Medical Sciences. 
In this study we considered the term “Developmental 
Disability” for all patients with developmental delay 
or regression. Cerebral palsy (CP) was considered as a 
group of permanent disorders of movement and posture, 
causing activity limitation and static encephalopathy 
in the developing fetal or infant brain. Intrapartum 
asphyxia was diagnosed on the basis of a combination 
of a history and objective documentation of different 
intrapartum complications. Autism was considered to be 
present when repetitive behaviors, desire for sameness, 
(1). It is demonstrated only about half of the children 
with developmental impairment are detected before 
school age (3).
Developmental delays are a group of etiologically 
heterogeneous, chronic disorders with a documented 
disturbance in one or more recognized developmental 
domains; these domains are: motor (gross or fine), 
speech/language, cognitive, social, and activities of daily 
living. The disturbance generally must be significant, 
which means a performance of more than or equal to 2 
standard deviations below the mean on a standardized 
developmental assessment. Global developmental 
delay (GDD) is described as significant delay in two or 
more developmental domains (gross motor, fine motor, 
cognition, speech/language, and personal/social) (2). Its 
estimated prevalence is 1–3% in children aged less than 
5 years (4). Typically, if there is delay in two domains, 
this can mean that there is a delay across all domains. 
When a single domain is affected, a gross motor delay or 
a developmental speech disorder exists (5). Speech delay 
is a common childhood developmental disorder that 
affects 3-10% of children (6). The term “delay” should 
be substituted by “impairment”, because the general 
population’s perception is that “delay” means something 
that will get in the end. But the term “impairment” does 
not suggest that the child will necessarily be normal 
eventually (7).
Recognition of children at risk for developmental delay 
and its associated problems can bring about intervention 
services and family assistance at an early age, that 
chances for improvement are high (5). Children with 
developmental disabilities have problems with social 
skills, memory, and emotional and cognitive functions 
as well as they have frequent comorbid psychopathology 
and challenging behaviors (8).
History and examination have the most importance in 
diagnosis. Studies show that history and examination 
can establish up to 34% of etiology of developmental 
delay. Laboratory investigations should be applied 
after taking a comprehensive history and performing a 
complete physical examination (9). 
Positive findings were observed in 30-60% of patients 
with significant developmental delay via newer 
techniques, such as high resolution computed tomography 
(CT) and magnetic resonance imaging (MRI) (10). 
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“Developmental Speech Delay”. All children that had 
motor delay and were normal in other aspects and 
physical examination, with familial history of motor 
delay and normal paraclinical study, were considered 
as “Familial Motor delay” At initial assessment, an 
information sheet was completed on each subject for 
all patients by a child neurologist. Specific laboratory 
testings were performed on a case-by-case basis (14) 
and brain imaging, metabolic screening, EEG, EMG–
NCV, ABR(16), audiometry, VEP, and genetic tests 
avoidance of eye contact, social isolation, and lack of 
imaginative play were characteristics that were evident 
on either history or neurodevelopmental examination. 
Chromosomal etiology defined as a genetic abnormality 
that is obvious on karyotype analysis. Genetic etiology 
indicates all other syndromes with known genetic 
cause. Cerebral dysgenesis was defined with features 
on neuroimaging. All children that were late talker 
and were normal in other developmental aspects, with 







Hypoxic Ischemic Encephalopathy 15 23 1
Kernicterus 3 6 -
Viral Encephalitis 2 - -
Head Trauma 2 1 -
Metabolic Disorders 7 1 -
Neurodegenerative Disorders 12 - -
Brain dysgenesis 14 3 -
Genetic disorders 14 - 1
Chronic systemic disorders(cystic fibrosis) 1 - -
Congenital brain mass 1 - -
TORCH (Toxoplasmosis) 1 - -
Pervasive developmental Disorders 2 - 2
Congenital Muscular Dystrophy 1 - -
Spinal Muscular Atrophy - 1 -
Muscular dystrophy - 1 -
Congenital Myopathy - 1 -
Landau Kleffner syndrome - - 3
Developmental speech Delay - - 10
Familial Motor Delay - 6 -
Hyper mobility Syndrome - 2 -
Neurocutaneous syndromes(Tuberous Sclerosis) 2 - -
meningitis 1 - -
Neonatal Hydrocephaly - - 1
Epileptic Encephalopathy 1 - -
Unknown 29 12 13
Table 1. The Etiologies of Neurodevelopmental Disability in Studied Groups
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(karyotyping and single gene study such as MECP2), 
were selected according to primary clinical diagnosis. 
We did not evaluate Intellectual Quotient (IQ) in our 
patients. At least 6-month follow-up was done to confirm 
diagnosis. 
Results
A total of 198 children (129 boys and 69 girls) with 
the mean age of 26.18±16.29 months (a range age of 2 
months to 65 months) were eligible for our study.
The chief complaints and histories of patients were in 
87% developmental delay and in 13% developmental 
regression. 
108 children (54.5%) had global developmental 
disability (80.5% delay and 19.5% regression) and 90 
children (45.5%) had isolated developmental disability 
(94.5% delay and 5.5% regression).
Patients with isolated developmental disability had 
29.7% motor, 15.6% speech and 1% cognition problems. 
The parents of children were relative in 38% of children 
and the history of developmental disability in family was 
positive in 30% of patients. 31.3% of children had the 
history of seizure during their life. 
CP was the most common clinical syndrome in all 
patients (41.4%). CP was seen in 42.6% of cases in 
global developmental disability group and 63.1% of 
cases in isolated motor developmental disability group. 
Developmental speech delay was the most common 
clinical syndrome in isolated speech disability group 
(38.7%).
Hypoxic ischemic encephalopathy (HIE) was the cause 
of developmental delay in 22.6% of all children (13.8 % 
of global and 41 % of motor delay) (Table1).
Metabolic disorder was demonstrated in 8 patients (4%), 
which included 3 Mucopolysaccharidoses, 2 maple 
syrup urine diseases, 2 Phenylketonuria, 1 galactosemia 
and 1 renal tubular acidosis.
12 children had clinical manifestations of 
neurodegenerative disorders, but definite diagnosis 
was determined in 4 patients (1 Adrenoleukodystrophy, 
1 neuronal ceroid lipofuscinoses, 1 Krabbe disease, and 
1 infantile bilateral striatal necrosis). In patients with 
autistic feature (17 children) etiologies were determined 
in 35.2% (HIE, brain dysgenesis, metabolic disorders) 
and in the others, etiologies were unknown.
9 children had specific genetic disorders (2 Down 
syndrome, 1 trisomy 18, 1 Rubinstein-Taybi syndrome, 
1 Cockayne syndrome, 1 Rett syndrome, 1 tuberous 
sclerosis, 1 Neurofibromatosis, 1 Spinal Muscular 
Atrophy disorder). 
In 25.7% of all patients, no specific etiology was 
identified for developmental disability (25.9% in global, 
21% in motor and 35.5% in speech).
Discussion
In this prospective descriptive study, an etiology 
was determined in about ¾ of children with global 
developmental disability but in patient with global 
developmental disability and autistic feature, this rate 
was about one third. Hypoxic ischemic encephalopathy 
(13.8%), brain dysgenesis (13%), genetic disorder (13%) 
and neurodegenerative diseases (11%) were specified 
etiologies in one half of all children with GDD.
A subspecialists’ evaluation of young children with GDD 
in Canada demonstrated the presence of co-existing 
autistic traits was related with significantly decreased 
diagnostic yield. In that study, four diagnoses (cerebral 
dysgenesis, hypoxic-ischemic encephalopathy, toxin 
exposure, chromosomal abnormalities) were responsible 
for 77% of the diagnoses made (14). Since in the present 
study we did not assay serum lead level in patients with 
GDD therefore toxin exposure was not a demonstrated 
cause in our survey.
In a similar cohort study in India, the etiological 
yield in young children with GDD was 73% and four 
diagnostic categories including Down syndrome (20%), 
HIE (15%), multiple malformation syndromes (14%), 
and cerebral dysgenesis (11%) were the most common 
causes of GDD (15). The result of this study was very 
similar to our finding but Down syndrome was not a 
common reason for referral in our patients. Inborn error 
of metabolism was not a common reason for GDD in 
our study, but in situations where developmental delay 
is associated with specific finding such as hypotonia, 
regression, eye abnormalities or hepatosplenomegaly, 
investigations are valuable (2).
CP was the most common clinical presentation in our 
patients (41.4%). we considered all children with static 
encephalopathy and motor impairment as CP. In a 
retrospective study conducted at a tertiary care centre in 
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north India, CP was demonstrated in 12.7% of patients 
but authors considered non chromosomal syndromes 
(9.5%), central nervous system structural defects (7.4%), 
and environmental insults (2%) in different categories 
(17).
Speech development delay may be a symptom of 
other diseases, such as mental retardation, expressive 
language disorder, hearing loss, autism, and CP. Speech 
delay may be secondary to maturation (developmental 
language delay). Maturation delay is responsible for a 
significant percentage of late talkers. Family history of 
“late bloomers” is often present in this condition (6).
Despite mental retardation is the most common cause 
of the chief complaint of “speech delay”, accounting for 
more than 50% of cases (6), in our study “developmental 
speech delay” was the common cause of isolated speech 
delay. In our method, all children with both cognition 
and speech delay were considered to be GDD.
In conclusion, Determination of an underlying etiology 
is an essential part of specialty evaluation of young 
children with developmental disability and helps for 
appropriate rehabilitation, family counseling and 
management of any associated medical conditions.
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